HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cutaneous T-cell lymphoma presenting as a rapidly enlarging ocular adnexal tumor.

Abstract
A 63-year-old man, in good health previously, developed swelling and erythema of the right upper eyelid which progressed to involve both eyelids and surrounding tissues. After one month, he had a 9.0 x 9.0 x 3.5 cm mass despite two attempts at incisional drainage and treatment with antibiotics. Multiple asymptomatic erythematosus nodules (2-3 cm in diameter) developed on his back, trunk, and arms four weeks after onset of the eyelid erythema and swelling. Biopsies of two upper back papules and the eyelid disclosed cutaneous T-cell lymphoma, a lymphoproliferative malignancy of thymus derived lymphocytes originating in the skin. Systemic chemotherapy resulted in a marked decrease in the ocular adnexal mass but lymphomatous meningitis and quadriplegia developed. The patient died four months later; an autopsy was not performed. This case demonstrates that cutaneous T-cell lymphoma may rarely have its initial manifestation as a rapidly enlarging eyelid tumor.
AuthorsB Meekins, A D Proia, G K Klintworth
JournalOphthalmology (Ophthalmology) Vol. 92 Issue 9 Pg. 1288-93 (Sep 1985) ISSN: 0161-6420 [Print] UNITED STATES
PMID3877264 (Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Eyelid Neoplasms (drug therapy, etiology, pathology)
  • Humans
  • Lymphoma (complications, drug therapy, pathology)
  • Male
  • Microscopy, Electron
  • Middle Aged
  • Skin Neoplasms (complications, drug therapy, pathology)
  • T-Lymphocytes (ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: